Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Management of Engraftment Arrhythmias Associated with Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Transplantation.

Heart rhythm·2026
Same author

Risk of antidepressant-induced hyponatremia in geriatric patients: a systematic review and meta-analysis.

BMC geriatrics·2026
Same author

Imipramine inhibits feline infectious peritonitis virus infection by targeting host cholesterol metabolism via NPC1.

Antimicrobial agents and chemotherapy·2026
Same author

Examination and therapeutic evaluation of individuals afflicted with profound thrombocytopenia triggered by tirofiban: A retrospective cohort study.

Medicine·2026
Same author

Development and internal validation of an early postnatal nomogram for bronchopulmonary dysplasia in very preterm infants with positive respiratory tract Ureaplasma urealyticum results.

BMC pediatrics·2026
Same author

Boron-mediated pectin demethylesterification improves Na<sup>+</sup> retention in root cell wall and alleviates salt stress in Brassica napus L.

Plant science : an international journal of experimental plant biology·2026

Related Experiment Video

Updated: Jun 30, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Multi-dimensional orchestration of binders for improved CAR-T immunotherapy.

Chaoyang Zhu1, Zhiwu Jiang1, Rui Jing1

  • 1Houston Methodist Neal Cancer Center, Weill Cornell Medicine, Houston, TX, 77030, USA.

Cancer Letters
|June 28, 2026
PubMed
Summary
This summary is machine-generated.

Optimizing chimeric antigen receptor (CAR)-T cell therapy requires a multidimensional binder design strategy, integrating multiple parameters beyond affinity for enhanced efficacy and safety in cancer treatment.

Keywords:
BindersCAR engineeringCAR-T immunotherapyClinical translationTumor-associated antigens

More Related Videos

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Related Experiment Videos

Last Updated: Jun 30, 2026

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography
09:34

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Area of Science:

  • Immunology
  • Biotechnology
  • Cancer Therapy

Background:

  • Antigen-binding domains (binders) are critical components in chimeric antigen receptor (CAR)-T cell engineering.
  • Binder properties significantly influence CAR-T cell selectivity, signaling, persistence, and toxicity.

Purpose of the Study:

  • To review advances in binder design for CAR-T cell therapy.
  • To propose a multidimensional design strategy for optimal CAR performance.
  • To highlight the impact of binder design on clinical translation.

Main Methods:

  • Synthesis of recent research on binder design parameters.
  • Analysis of how epitope position, kinetics, avidity, geometry, and stability impact CAR-T cell function.
  • Examination of the expanding landscape of binder formats.

Main Results:

  • Optimal CAR performance necessitates integrating multiple binder design parameters, not just affinity.
  • These parameters collectively regulate immunological synapse formation, antigen discrimination, and functional durability.
  • Binder design choices have significant clinical implications.

Conclusions:

  • A shift from empirical selection to rational orchestration of binders is crucial for next-generation CAR-T therapies.
  • Multidimensional binder design is foundational for improving CAR-T cell immunotherapy.
  • Integrating diverse binder formats, including novel engineered proteins, expands therapeutic potential.